Therefore, we aimed to investigate DNMT1, DNMT3A, DNMT3B, and H3K9ac immunohistochemical expression in the most prevalent and locally aggressive benign odontogenic tumor, ameloblastoma, and compare this with its malignant counterpart, ameloblastic carcinoma (AC). This evidence concerns the gene DNMT3B and ameloblastic carcinoma.